Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 14/20 | 0.55 |
| ▸ | CPB1 | P15086 | 5/20 | 0.55 |
| ▸ | KDM5A | P29375 | 1/20 | 0.44 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.39 |
| ▸ | KDM2B | Q8NHM5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8349794 | 0.83 | LMNA (0.45) | CPB2CPB1KDM5AKDM5BSLC6A3 | |
| SCHEMBL6326270 | 0.83 | CPB2 (0.65) | CPB2CPB1KDM5AKDM5B | |
| SCHEMBL7196421 | 0.83 | CPB2 (0.65) | CPB2CPB1KDM5AKDM5B | |
| SCHEMBL8346104 | 0.82 | CPB2 (0.62) | CPB2CPB1 | |
| SCHEMBL10137873 | 0.78 | CPB2 (0.64) | CPB2CPB1KDM5AKDM5B | |
| SCHEMBL10583023 | 0.77 | CPB2 (0.64) | CPB2CPB1KDM5AKDM5B | |
| SCHEMBL6328167 | 0.77 | CPB2 (0.64) | CPB2CPB1KDM5AKDM5B | |
| SCHEMBL6333894 | 0.75 | KDM4D (0.46) | CPB2CPB1 | |
| SCHEMBL8366596 | 0.74 | MEN1 (0.40) | CPB2CPB1 | |
| SCHEMBL6326796 | 0.73 | CPB2 (0.65) | CPB2CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003061653-A9 | 3-(IMIDAZOLYL)-2-AMINOPROPANOIC ACIDS FOR USE AS TAFI-A INHIBITORS FOR THE TREATMENT OF THROMBOTIC DISEASES | PFIZER LTD (GB) | 2003-12-24 | — | — | WO | disclosed |